Mary Rotto, PA
Obstetrics & Gynecology · Ames, IANPI 1417939638
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 31.6% of the total. Reporting peaked in 2022 at $516 and has fallen 67.8% since, to $166 in 2025.
Across 104 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$623
- Astellas Pharma US Inc$331
- Bayer$137
- Pfizer$109
- Sumitomo Pharma America, Inc.$95
- Myovant Sciences Inc.$95
- plus $581 from 13 others
What the payments were for
- Food & beverage$1,80692%
- Education$1658%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $623 |
| Astellas Pharma US Inc | 10 | $331 |
| Bayer | 8 | $137 |
| Pfizer | 6 | $109 |
| Sumitomo Pharma America, Inc. | 5 | $95 |
| Myovant Sciences Inc. | 6 | $95 |
| Mayne Pharma Commercial LLC | 6 | $82 |
| Exeltis, USA Inc. | 5 | $75 |
| Coopersurgical, Inc. | 3 | $67 |
| Therapeuticsmd, Inc. | 4 | $62 |
| Idorsia Pharmaceuticals US Inc | 3 | $59 |
| Hologic Sales And Service, LLC | 3 | $50 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Medtronic | 1 | $28 |
| Agile Therapeutics, Inc. | 2 | $25 |
| Solventum Corporation | 1 | $24 |
| Davol Inc. | 1 | $23 |
| Merck | 1 | $21 |
| Biogen | 1 | $18 |
How this compares
$1,971 in reported general payments places this provider in the 80th percentile of 274 obstetrics & gynecology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 43 | $3,617 |
| Medroxyprogesterone Acetate | 11 | $380 |
| Solifenacin Succinate | 12 | $178 |
| Nystatin | 12 | $133 |
| Alendronate Sodium | 19 | $58 |
| Triamcinolone Acetonide | 14 | $46 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Ames
- Joyce LinesAmes$4K
- Emily ZoulekAmes$3K
- Jorge SotolongoCouncil Bluffs$171K
- Laura NealDubuque$157K
- Amy BingamanDes Moines$44K
- Alvadore OsbornWest Des Moines$34K
- Jason RexrothCedar Rapids$16K
- Maxwell MageeWest Des Moines$16K
- Lori PlattCouncil Bluffs$14K
- Heather MarthersWaterloo$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.